Posted by Michael Wonder on 03 Apr 2017
When $65,000 a year for a drug is applauded
3 April 2017 - Two new drugs were cleared to hit the market last week: an eczema drug that will cost $37,000 per year and one for multiple sclerosis that will cost $65,000.
The drugs drew both praise and criticism for their five-digit price tags.
Researchers and patient organizations applauded the prices, which were cheaper than similar drugs on the market. They hoped the prices would please insurers and make the drugs more widely available.
"We encourage other companies to follow suit, creating a drug pricing trend that keeps patients first," said Cyndi Zagieboylo, president of the National Multiple Sclerosis Society, in a statement about the multiple sclerosis drug Ocrevus.
